These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26344911)

  • 1. Ynamide Click chemistry in development of triazole VEGFR2 TK modulators.
    Vojtičková M; Dobiaš J; Hanquet G; Addová G; Cetin-Atalay R; Yildirim DC; Boháč A
    Eur J Med Chem; 2015 Oct; 103():105-22. PubMed ID: 26344911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A development of chimeric VEGFR2 TK inhibitor based on two ligand conformers from PDB: 1Y6A complex--medicinal chemistry consequences of a TKs analysis.
    Lintnerová L; García-Caballero M; Gregáň F; Melicherčík M; Quesada AR; Dobiaš J; Lác J; Sališová M; Boháč A
    Eur J Med Chem; 2014 Jan; 72():146-59. PubMed ID: 24368209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro evaluation of potential anticancer activity of mono- and bis-1,2,3-triazole derivatives of bis-alkynes.
    Elamari H; Slimi R; Chabot GG; Quentin L; Scherman D; Girard C
    Eur J Med Chem; 2013 Feb; 60():360-4. PubMed ID: 23314049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 1,4-disubstituted 1,2,3-triazole Derivatives Using Click Chemistry and their Src Kinase Activities.
    Lebeau A; Abrioux C; Bénimèlis D; Benfodda Z; Meffre P
    Med Chem; 2016; 13(1):40-48. PubMed ID: 27041552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR.
    Khattab RR; Alshamari AK; Hassan AA; Elganzory HH; El-Sayed WA; Awad HM; Nossier ES; Hassan NA
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):504-516. PubMed ID: 33504239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Click-chemistry mediated synthesis of OTBN-1,2,3-Triazole derivatives exhibiting STK33 inhibition with diverse anti-cancer activities.
    Vala DP; Dunne Miller A; Atmasidha A; Parmar MP; Patel CD; Upadhyay DB; Bhalodiya SS; González-Bakker A; Khan AN; Nogales J; Padrón JM; Banerjee S; Patel HM
    Bioorg Chem; 2024 Aug; 149():107485. PubMed ID: 38824700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics.
    Oguro Y; Cary DR; Miyamoto N; Tawada M; Iwata H; Miki H; Hori A; Imamura S
    Bioorg Med Chem; 2013 Aug; 21(15):4714-29. PubMed ID: 23755884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
    Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
    Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
    Lu L; Zhao TT; Liu TB; Sun WX; Xu C; Li DD; Zhu HL
    Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1570-1575. PubMed ID: 27568484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses.
    Rezki N; Almehmadi MA; Ihmaid S; Shehata AM; Omar AM; Ahmed HEA; Aouad MR
    Bioorg Chem; 2020 Oct; 103():104133. PubMed ID: 32745759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors.
    Matsumoto S; Miyamoto N; Hirayama T; Oki H; Okada K; Tawada M; Iwata H; Nakamura K; Yamasaki S; Miki H; Hori A; Imamura S
    Bioorg Med Chem; 2013 Dec; 21(24):7686-98. PubMed ID: 24216091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
    Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors.
    Fischer T; Krüger T; Najjar A; Totzke F; Schächtele C; Sippl W; Ritter C; Hilgeroth A
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2708-2712. PubMed ID: 28478927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
    Khazir J; Hyder I; Gayatri JL; Prasad Yandrati L; Nalla N; Chasoo G; Mahajan A; Saxena AK; Alam MS; Qazi GN; Sampath Kumar HM
    Eur J Med Chem; 2014 Jul; 82():255-62. PubMed ID: 24910974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MGM
    Bioorg Med Chem Lett; 2018 May; 28(9):1464-1470. PubMed ID: 29628325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids.
    Bollu R; Palem JD; Bantu R; Guguloth V; Nagarapu L; Polepalli S; Jain N
    Eur J Med Chem; 2015 Jan; 89():138-46. PubMed ID: 25462234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity.
    Al-Hussain SA; Farghaly TA; Zaki MEA; Abdulwahab HG; Al-Qurashi NT; Muhammad ZA
    Bioorg Chem; 2020 Dec; 105():104330. PubMed ID: 33038552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New amide linked dimeric 1,2,3-triazoles bearing aryloxy scaffolds as a potent antiproliferative agents and EGFR tyrosine kinase phosphorylation inhibitors.
    Deshmukh TR; Sarkate AP; Lokwani DK; Tiwari SV; Azad R; Shingate BB
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126618. PubMed ID: 31431361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity.
    Nunes PSG; da Silva G; Nascimento S; Mantoani SP; de Andrade P; Bernardes ES; Kawano DF; Leopoldino AM; Carvalho I
    Bioorg Chem; 2021 Aug; 113():104982. PubMed ID: 34020277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural inspired piperine-based ureas and amides as novel antitumor agents towards breast cancer.
    Elimam DM; Elgazar AA; El-Senduny FF; El-Domany RA; Badria FA; Eldehna WM
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):39-50. PubMed ID: 34894962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.